Extrapolation of Survival Data Using a Bayesian Approach: A Case Study Leveraging External Data from Cilta-Cel Therapy in Multiple Myeloma Stephen PalmerYi LinGraham Jackson Original Research Open access 04 June 2023 Pages: 313 - 326
Patient Perceptions of CAR-T Therapy in the USA: Findings from In-Depth Interviews Todd J. BixbyChristine J. BrittleLisa R. Kallenbach Original Research Open access 21 May 2023 Pages: 303 - 312
Diagnostic and Treatment Obstacles in Acute Myeloid Leukemia: Social, Operational, and Financial Emine Eylem Gençİrem Sena SaraçAhmet Emre Eşkazan Commentary Open access 13 May 2023 Pages: 145 - 152
Component Costs of CAR-T Therapy in Addition to Treatment Acquisition Costs in Patients with Multiple Myeloma Sundar JagannathNedra JosephAdam D. Cohen Original Research Open access 04 April 2023 Pages: 263 - 275
Real-World Outcomes Following First-Line Treatment in Patients with Advanced Ovarian Cancer with Multiple Risk Factors for Disease Progression who Received Maintenance Therapy or Active Surveillance Dana ChaseJessica PerhanidisAntonio González-Martín Original Research Open access 04 April 2023 Pages: 245 - 261
The Future of Breast Cancer Research in the Survivorship Field D. SoldatoL. AreccoM. Lambertini Review Open access 01 April 2023 Pages: 199 - 229
Induction Therapy for Locally Advanced Head and Neck Squamous Cell Carcinoma Shuwen ZhengYumei FengKe Xie Review Open access 21 March 2023 Pages: 185 - 198
Immune Checkpoint Inhibitors in Breast Cancer: A Narrative Review Paulo Nunes FilhoCaroline AlbuquerqueMarcio Debiasi Review Open access 14 March 2023 Pages: 171 - 183
Development of a Conceptual Model of the Patient Experience in Small Cell Lung Cancer: A Qualitative Interview Study Danielle E. AltmanXinke ZhangVivek Pawar Original Research Open access 17 February 2023 Pages: 231 - 244
Biochemistry—Not Oncogenes—May Demystify and Defeat Cancer Jay Kulsh Review Open access 13 February 2023 Pages: 153 - 169
Correction: Patients at the Heart of the Scientific Dialogue: An Industry Perspective Dany HabrBrittany Wolf GianaresDheepa Chari Correction Open access 07 February 2023 Pages: 25 - 25
Patients at the Heart of the Scientific Dialogue: An Industry Perspective Dany HabrBrittany Wolf GianaresDheepa Chari Commentary Open access 27 January 2023 Pages: 15 - 24
Liposomal Irinotecan Shows a Larger Therapeutic Index than Non-liposomal Irinotecan in Patient-Derived Xenograft Models of Pancreatic Cancer Sandrine BarbierBenjamin BeaufilsFlorence Meyer-Losic Original Research Open access 16 January 2023 Pages: 111 - 128
A Mixed-Methods Study to Better Measure Patient-Reported Pain and Fatigue in Soft Tissue Sarcoma Louise BarrettEmma ElliottStefan Cano Original Research Open access 12 January 2023 Pages: 129 - 143
Role of Perioperative Immune Checkpoint Inhibitors in Muscle Invasive Bladder Cancer Saachi ChhayaIsabella WattsNikhil Vasdev Review Open access 03 January 2023 Pages: 49 - 64
Emerging Concepts Impacting Head and Neck Cancer Surgery Morbidity Ohad RonenK. Thomas RobbinsAlfio Ferlito Commentary Open access 24 December 2022 Pages: 1 - 13
RETRACTED ARTICLE: Tarsoconjunctival Granulation Tissue Formation Associated with EGFR Inhibitors Ferhan GulerNilay YukselMehmet Ali Nahit Sendur Case Report Open access 21 December 2022 Pages: 391 - 396
Real-World Outcomes of Belantamab Mafodotin for Relapsed/Refractory Multiple Myeloma (RRMM): Preliminary Results of a Spanish Expanded Access Program (EAP) Adrián AlegreGonzalo BenzoGrupo GM-GM Original Research Open access 12 December 2022 Pages: 83 - 96
Breast Cancer Survival Outcomes and Tumor-Associated Macrophage Markers: A Systematic Review and Meta-Analysis Eleanor AllisonSenarath EdirimanneStephen J. Fuller Review Open access 09 December 2022 Pages: 27 - 48
Clinical Characteristics and Management of Children and Adults with Neurofibromatosis Type 1 and Plexiform Neurofibromas in Denmark: A Nationwide Study Cecilie EjerskovStense FarholtMette Møller Handrup Original Research Open access 01 December 2022 Pages: 97 - 110
Healthcare Resource Utilization and Associated Costs of German Patients with Diffuse Large B-Cell Lymphoma: A Retrospective Health Claims Data Analysis Peter BorchmannJan-Michel HegerBarbara Werner Original Research Open access 29 November 2022 Pages: 65 - 81
The Anticancer Effect of Metformin Combined with Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Non-small Cell Lung Cancer Patients with or Without Type 2 Diabetes Mellitus: A Systematic Review and Meta-analysis Qiman ZhangJin ZhengFei-Long Wei Review Open access 25 October 2022 Pages: 363 - 375
The Role of Electronic Patient-Reported Outcome Measures in Assessing Smoking Status and Cessation for Patients with Lung Cancer James ConvillFiona BlackhallFabio Gomes Original Research Open access 12 October 2022 Pages: 481 - 491
Lanreotide Depot to Treat Gastroenteropancreatic Neuroendocrine Tumors in a US Community Oncology Setting: A Prospective, Observational Study Scott PaulsonDavid RayEric Liu Original Research Open access 22 September 2022 Pages: 463 - 479
Pegfilgrastim Biosimilars in US Supportive Oncology: A Narrative Review of Administration Options and Economic Considerations to Maximize Patient Benefit Sophia Z. HumphreysRobert B. GellerPaul Walden Review Open access 16 September 2022 Pages: 351 - 361
Expression and Prognostic Significance of Stem Cell Marker CD133 in Survival Rate of Patients with Colon Cancer Hassan EhteramFatemeh AslanbeigiHamed Haddad Kashani Original Research Open access 18 August 2022 Pages: 451 - 461
The Implementation of Minimally Invasive Surgery in the Treatment of Esophageal Cancer: A Step Toward Better Outcomes? Tania TriantafyllouPieter van der SluisBas P. L. Wijnhoven Review Open access 10 August 2022 Pages: 337 - 349
MRI Grading Scale Predicts Ambulatory Function After Radiotherapy for Metastatic Spinal Cord Compression: A Prospective Single-Institution Observational Study Natsuko YanoTakashi OnoKenji Nemoto Brief Report Open access 19 July 2022 Pages: 493 - 501
Minimally Invasive Pancreatoduodenectomy: Contemporary Practice, Evidence, and Knowledge Gaps Jacob GhotbiMushegh SahakyanDyre Kleive Commentary Open access 12 July 2022 Pages: 301 - 315
Breast Cancer with Low Recurrence Score on Oncotype DX©: Interplay Between Early Recurrence, Lobular Histology and BRCA Mutation Yonaton ZarbivYael Berner WygodaLuna Kadouri Original Research Open access 25 June 2022 Pages: 441 - 450
Basal Cell Carcinoma: A Narrative Review on Contemporary Diagnosis and Management Piyu Parth NaikMunaf B. Desai Review Open access 21 June 2022 Pages: 317 - 335
Patient, Family Member and Physician Perspectives and Experiences with AML Treatment Decision-Making Thomas W. LeBlancNigel H. RussellRoland B. Walter Original Research Open access 13 June 2022 Pages: 421 - 440
Healthcare Costs of Multiple Myeloma Patients with Four or More Prior Lines of Therapy, Including Triple-Class Exposure in the United States Sundar JagannathNedra JosephNina Shah Original Research Open access 17 May 2022 Pages: 411 - 420
Cost-Effectiveness of PD-L1 Testing in Non-Small Cell Lung Cancer (NSCLC) Using In Vitro Diagnostic (IVD) Versus Laboratory-Developed Test (LDT) Jason T. HurwitzShannon VaffisSuzanne Parry Original Research Open access 13 May 2022 Pages: 391 - 409
Correction to: The Effect of Irisin on Proliferation, Apoptosis, and Expression of Metastasis Markers in Prostate Cancer Cell Lines Atiye Saeedi SadrHassan EhteramHamed Haddad Kashani Correction Open access 12 May 2022 Pages: 389 - 389
The Effect of Irisin on Proliferation, Apoptosis, and Expression of Metastasis Markers in Prostate Cancer Cell Lines Atiye Saeedi SadrHassan EhteramHamed Haddad Kashani Original Research Open access 25 April 2022 Pages: 377 - 388
Current Role of Allogeneic Stem Cell Transplantation in Multiple Myeloma Jean-Sébastien ClaveauFrancis K. BuadiShaji Kumar Review Open access 04 April 2022 Pages: 105 - 122
Stapler-Assisted Pharyngeal Closure After Total Laryngectomy: A Systematic Review and Meta-Analysis Carlos M. Chiesa-EstombaMiguel Mayo-YanezAlfio Ferlito Original Research Open access 31 March 2022 Pages: 241 - 252
Impact of the COVID-19 Pandemic on Breast Cancer Management in Portugal: A Cross-Sectional Survey-Based Study of Medical Oncologists Diogo Alpuim CostaJosé Guilherme Gonçalves NobreNoémia Afonso Original Research Open access 21 March 2022 Pages: 225 - 240
Measuring the Patient Experience in Rare Disorders: Benefit of Pragmatic Mixed-Methods Research in NUT Carcinoma Anna CieslukMaarten VoorhaarPatrick Marquis Brief Report Open access 17 March 2022 Pages: 263 - 277
ADAURA: The Splash of Osimertinib in Adjuvant EGFR-Mutant Non-small Cell Lung Cancer Ana Ortega-FrancoShereen Rafee Commentary Open access 16 March 2022 Pages: 13 - 22
Exploratory Analysis Comparing Fosnetupitant Versus Fosaprepitant for Prevention of Highly Emetogenic Chemotherapy-Induced Nausea and Vomiting (CINV): A Randomized, Double-Blind, Phase 3 Study (CONSOLE) Akito HataYoshimasa ShiraishiTomohide Tamura Brief Report Open access 04 March 2022 Pages: 253 - 262
Patient and Healthcare Professional Perspectives from ESMO 2021 on Bladder and Kidney Cancer: A Podcast Alex FilicevasThomas B. Powles Commentary Open access 03 March 2022 Pages: 1 - 11
Estimating the Impact of Delayed Access to Oncology Drugs on Patient Outcomes in Canada Jackie Vanderpuye-OrgleDaniel ErimDarren R. Brenner Original Research Open access 01 March 2022 Pages: 195 - 210
Parenteral Nutrition in Advanced Cancer: The Healthcare Providers’ Perspective Trude R. BalstadErik T. LøhreKari Sand Original Research Open access 24 February 2022 Pages: 211 - 223
Soluble Programmed Death-Ligand 1 (sPD-L1) is Elevated in Aggressive Prostate Cancer Disease Among African Men Paul KatongoleObondo J. SandeNixon Niyonzima Original Research Open access 07 February 2022 Pages: 185 - 193
Donor-Derived Leukemia in a Recipient of Double-Unit Cord Blood Transplantation for Acute Myeloid Leukemia: A Case Study and Literature Review Adriana PlesaIsabelle TigaudXavier Thomas Review Open access 07 February 2022 Pages: 75 - 84
Cellular Immunotherapies for Multiple Myeloma: Current Status, Challenges, and Future Directions Zhi-Ling YanYue-Wen WangYing-Jun Chang Review Open access 01 February 2022 Pages: 85 - 103
Inflamed Tumor Phenotype as Predictor of Long-Term Response to Pembrolizumab in an EGFR-Mutated Non-Small Cell Lung Cancer (NSCLC) Patient with Acquired Resistance to Afatinib: a Case Report and Review of the Literature Sara BaglivoMartina MandaranoGiulio Metro Case Report Open access 23 January 2022 Pages: 291 - 300
Addition of Immune Checkpoint Inhibitors to Chemotherapy vs Chemotherapy Alone as First-Line Treatment in Extensive-Stage Small-Cell Lung Carcinoma: A Systematic Review and Meta-Analysis Edurne ArriolaMaría González-CaoDolores Isla Original Research Open access 15 January 2022 Pages: 167 - 184